Attributes | Values |
---|
rdf:type
| |
Description
| - The results indicate that structurally different DNA adducts of antitumor trinuclear platinum compound BBR3464 and cisplatin exhibit a different efficiency to affect the binding affinity of the modified DNA to p53 protein. It has been suggested that different structural perturbations induced in DNA by the adducts of BBR3464 and cisplatin produce differential response to p53 protein activation.
- The results indicate that structurally different DNA adducts of antitumor trinuclear platinum compound BBR3464 and cisplatin exhibit a different efficiency to affect the binding affinity of the modified DNA to p53 protein. It has been suggested that different structural perturbations induced in DNA by the adducts of BBR3464 and cisplatin produce differential response to p53 protein activation. (en)
- Výsledky ukazují, že strukturně odlišné adukty protinádorově účinného trojjaderného komplexu platiny BBR3464 a cisplatiny vykazují odlišnou účinnost ovlivňovat vazebnou afinitu modifikované DNA k proteinu p53. Bylo navrženo, že odlišná narušení struktury vyvolaná v DNA adukty BBR3464 a cisplatiny jsou signálem pro odlišnou odpověď na aktivaci proteinu p53. (cs)
|
Title
| - Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin
- Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin (en)
- Odlišné rozlišení DNA modifikované novým protinádorově účinným trojjaderným komplexem platiny BBR3464 a cisplatinou nádorově supresorovým proteinem p53 (cs)
|
skos:prefLabel
| - Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin
- Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin (en)
- Odlišné rozlišení DNA modifikované novým protinádorově účinným trojjaderným komplexem platiny BBR3464 a cisplatinou nádorově supresorovým proteinem p53 (cs)
|
skos:notation
| - RIV/68081707:_____/04:00104638!RIV/2005/AV0/A17005/N
|
http://linked.open.../vavai/riv/strany
| |
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - P(GA204/02/0734), P(IAA5004101), P(IBS5004009), P(KJB5004301), P(KSK4055109), Z(AV0Z5004920)
|
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/68081707:_____/04:00104638
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| |
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - GB - Spojené království Velké Británie a Severního Irska
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| |
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Brabec, Viktor
- Fojta, Miroslav
- Kašpárková, Jana
- Farrell, N.
|
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |